Zhejiang Jolly Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 17.96% vs 11.88% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 62.51% vs -10.51% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "897.80",
          "val2": "761.10",
          "chgp": "17.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "217.70",
          "val2": "132.30",
          "chgp": "64.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.10",
          "val2": "3.80",
          "chgp": "7.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "202.00",
          "val2": "124.30",
          "chgp": "62.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "242.50%",
          "val2": "145.20%",
          "chgp": "9.73%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 18.42% vs 32.27% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 24.50% vs 32.04% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,018.20",
          "val2": "2,548.80",
          "chgp": "18.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "832.10",
          "val2": "665.60",
          "chgp": "25.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.60",
          "val2": "9.40",
          "chgp": "55.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "642.40",
          "val2": "516.00",
          "chgp": "24.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "247.70%",
          "val2": "231.60%",
          "chgp": "1.61%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

897.80

761.10

17.96%

Operating Profit (PBDIT) excl Other Income

217.70

132.30

64.55%

Interest

4.10

3.80

7.89%

Exceptional Items

0.00

0.00

Consolidate Net Profit

202.00

124.30

62.51%

Operating Profit Margin (Excl OI)

242.50%

145.20%

9.73%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 17.96% vs 11.88% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 62.51% vs -10.51% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,018.20

2,548.80

18.42%

Operating Profit (PBDIT) excl Other Income

832.10

665.60

25.02%

Interest

14.60

9.40

55.32%

Exceptional Items

-1.70

0.00

Consolidate Net Profit

642.40

516.00

24.50%

Operating Profit Margin (Excl OI)

247.70%

231.60%

1.61%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 18.42% vs 32.27% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 24.50% vs 32.04% in Dec 2024

All Annual Results